Bowen Hanes & CO Inc Johnson & Johnson Transaction History

Bowen Hanes & CO Inc

$3.8 Billion
Q3 2024

A detailed history of Bowen Hanes & CO Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Bowen Hanes & CO Inc holds 40,981 shares of JNJ stock, worth $5.94 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

40,981

Previous 43,731 6.29%

Holding current value

$5.94 Million

Previous $6.39 Million 3.91%

% of portfolio

0.17%

Previous 0.18%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$145.48 - $167.38 $400,070 - $460,295	-2,750 Reduced 6.29%	40,981 $6.64 Million
Q2 2024 Aug 12, 2024	SELL	$144.38 - $157.78 $1.04 Million - $1.14 Million	-7,233 Reduced 14.19%	43,731 $6.39 Million
Q1 2024 May 13, 2024	SELL	$155.22 - $162.74 $32.9 Million - $34.5 Million	-212,121 Reduced 80.63%	50,964 $8.06 Million
Q4 2023 Feb 12, 2024	SELL	$145.6 - $158.88 $1.81 Million - $1.97 Million	-12,415 Reduced 4.51%	263,085 $41.2 Million
Q3 2023 Nov 13, 2023	SELL	$155.75 - $174.48 $232,846 - $260,847	-1,495 Reduced 0.54%	275,500 $42.9 Million
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $161,758 - $174,083	1,048 Added 0.38%	276,995 $45.8 Million
Q1 2023 May 11, 2023	SELL	$151.05 - $180.26 $3.57 Million - $4.26 Million	-23,620 Reduced 7.88%	275,947 $42.8 Million
Q4 2022 Feb 09, 2023	BUY	$160.2 - $179.79 $569,350 - $638,973	3,554 Added 1.2%	299,567 $52.9 Million
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $686,459 - $763,857	4,255 Added 1.46%	296,013 $48.4 Million
Q2 2022 Aug 12, 2022	BUY	$168.19 - $186.01 $2.19 Million - $2.43 Million	13,048 Added 4.68%	291,758 $51.8 Million
Q1 2022 May 12, 2022	SELL	$158.14 - $179.59 $524,234 - $595,340	-3,315 Reduced 1.18%	278,710 $49.4 Million
Q4 2021 Feb 11, 2022	SELL	$155.93 - $173.01 $12.1 Million - $13.4 Million	-77,669 Reduced 21.59%	282,025 $48.2 Million
Q3 2021 Nov 15, 2021	SELL	$161.5 - $179.47 $450,908 - $501,080	-2,792 Reduced 0.77%	359,694 $58.1 Million
Q2 2021 Aug 12, 2021	SELL	$159.48 - $171.07 $634,730 - $680,858	-3,980 Reduced 1.09%	362,486 $59.7 Million
Q1 2021 May 13, 2021	BUY	$153.07 - $170.48 $155,825 - $173,548	1,018 Added 0.28%	366,466 $60.2 Million
Q4 2020 Feb 08, 2021	BUY	$137.11 - $157.38 $100,775 - $115,674	735 Added 0.2%	365,448 $57.5 Million
Q3 2020 Feb 08, 2021	SELL	$140.38 - $153.83 $24,706 - $27,074	-176 Reduced 0.05%	364,713 $54.3 Million
Q3 2020 Nov 02, 2020	BUY	$140.38 - $153.83 $395,169 - $433,031	2,815 Added 0.78%	364,889 $54.3 Million
Q2 2020 Aug 14, 2020	SELL	$128.81 - $155.51 $442,462 - $534,176	-3,435 Reduced 0.94%	362,074 $50.9 Million
Q1 2020 May 14, 2020	BUY	$111.14 - $153.99 $341,977 - $473,827	3,077 Added 0.85%	365,509 $47.9 Million
Q4 2019 Feb 13, 2020	BUY	$127.5 - $146.44 $4.75 Million - $5.46 Million	37,290 Added 11.47%	362,432 $52.9 Million
Q3 2019 Nov 13, 2019	BUY	$126.95 - $142.14 $106,638 - $119,397	840 Added 0.26%	325,142 $42.1 Million
Q2 2019 Aug 13, 2019	BUY	$131.15 - $144.24 $99,674 - $109,622	760 Added 0.23%	324,302 $45.2 Million
Q1 2019 May 13, 2019	BUY	$125.72 - $139.79 $1.87 Million - $2.08 Million	14,882 Added 4.82%	323,542 $45.2 Million
Q4 2018 Feb 13, 2019	SELL	$122.84 - $147.84 $113,995 - $137,195	-928 Reduced 0.3%	308,660 $39.8 Million
Q3 2018 Nov 08, 2018	BUY	$121.58 - $142.88 $226,138 - $265,756	1,860 Added 0.6%	309,588 $42.8 Million
Q2 2018 Aug 14, 2018	BUY	$119.4 - $131.76 $66,028 - $72,863	553 Added 0.18%	307,728 $37.3 Million
Q1 2018 May 15, 2018	SELL	$125.1 - $148.14 $15,637 - $18,517	-125 Reduced 0.04%	307,175 $39.4 Million
Q4 2017 Feb 13, 2018	SELL	$131.22 - $143.62 $560,440 - $613,401	-4,271 Reduced 1.37%	307,300 $42.9 Million
Q3 2017 Nov 13, 2017	BUY	$129.47 - $135.38 $40.3 Million - $42.2 Million	311,571	311,571 $40.5 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $379B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bowen Hanes & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bowen Hanes & CO Inc with notifications on news.

Account

Bowen Hanes & CO Inc Johnson & Johnson Transaction History